Immunome, Inc. (IMNM)

Immunome Revenue

Immunome had revenue of $4.01M in the quarter ending June 30, 2025, with 69.84% growth. This brings the company's revenue in the last twelve months to $12.59M, up 16.74% year-over-year. In the year 2024, Immunome had annual revenue of $9.04M, down -35.50%.

• Revenue (ttm): $12.59M
• Revenue Growth: +16.74%
• P/S Ratio: 60.49
• Revenue / Employee: $106,686
• Employees: 118
• Market Cap: 915.71M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	9.04M	-4.98M	-35.50%
Dec 31, 2023	14.02M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.